A panel of federal health experts recommended expanded vaccine options for several diseases, including RSV, meningitis, and chikungunya.

Delayed initiation of broad-spectrum gram-negative antibiotic therapy was not linked to worse clinical outcomes among adult inpatients.

A federal team responsible for setting poverty guidelines that determine who qualifies for health and food assistance has been fired.

The likelihood of HCV clearance was increased by participation in Ryan White services among patients with HIV coinfection.

Patients with infection-related hospitalization may have increased risk for incident heart failure, including HFrEF and HFpEF.

Over the past 2 decades, stroke-related mortality among individuals with HIV has decreased, but racial and gender disparities continue to exist.

The risk for treatment failure and hospital readmission was lower among patients with MSSI BSIs who received high- vs standard-dose daptomycin as OPAT after discharge.

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

Five years after COVID-19 first hit the United States, scientists are already brainstorming how to stop the next big virus.

The FDA has cleared the Visby Medical Women's Sexual Health Test for use at home to test for chlamydia, gonorrhea, and ...

The US FDA announced it is shifting away from animal testing in the development of monoclonal antibody therapies and other drugs.

The FDA has approved a new freeze-dried formulation of Jynneos (smallpox and mpox vaccine, live, non-replicating).